Programme by Day

Print this page

  Personalized Programme
The Personalized Programme enables you to compile an individual programme with events and contributions of your interest. Therefore, it can be used very well to plan your actual congress visit at an early point of time. Please log on with your username and password to use the Personalized Programme.



» New User
» Help
   
  Plenary Session
Time: 08.30-10.00
Room: Ballroom BC
Session title: Future directions in ADHD
  Doron Almagor, Canada Chair
  Manfred Gerlach, Germany Co-Chair
     
  Plenary Session
Time: 10.30-12.00
Room: Ballroom BC
Session title: Pros and cons: The treatment of ADHD patients has long-term effects
     
  Katherine Ellison, USA
  David Coghill, Australia Proponent
  Klaus W. Lange, Germany Opponent
     
  Industry Supported Symposia
Time: 12.15-13.30
Room: East Meetingroom 1/2/3
Session title: Shire Symposium I: Sustaining the optimal management of ADHD in children and adolescents
  Kenny Handleman, Canada Chair
     
  What can we learn about optimal management of ADHD from MTA study?  
  Peter Jensen, USA Speaker
  Achieving and sustaining optimal management of ADHD in children and adolescents  
  David Coghill, Australia Speaker
  Duncan Manders, United Kingdom Discussant
  David Coghill, Australia Discussant
  Kenny Handleman, Canada Discussant
  Peter Jensen, USA Discussant
  Javier Quintero, Spain Discussant
  Luis Augusto Rohde, Brazil Discussant
     
  Guided Poster Tour
Time: 14.30-16.00
Room: Exhibit A
Session title: Aetiology I
  Edna Grünblatt, Switzerland Chair
     
  Guided Poster Tour
Time: 14.30-16.00
Room: Exhibit A
Session title: Aetiology II
  Barbara Franke, Netherlands Chair
     
  Guided Poster Tour
Time: 14.30-16.00
Room: Exhibit A
Session title: Epidemiology I
  Guilherme Polanczyk, Brazil Chair
     
  Guided Poster Tour
Time: 14.30-16.00
Room: Exhibit A
Session title: Epidemiology II
  Jeffrey Newcorn, USA Chair
     
  Guided Poster Tour
Time: 14.30-16.00
Room: Exhibit A
Session title: Diagnosis I
  Joseph Biederman, USA Chair
     
  Guided Poster Tour
Time: 14.30-16.00
Room: Exhibit A
Session title: Diagnosis II
  Marcel Romanos, Germany Chair
     
  Guided Poster Tour
Time: 14.30-16.00
Room: Exhibit A
Session title: Comorbidity
  Frieda Matthys, Belgium Chair
     
  Guided Poster Tour
Time: 14.30-16.00
Room: Exhibit A
Session title: Autism spectrum disorders
  Nanda Rommelse, Netherlands Chair
     
  Guided Poster Tour
Time: 14.30-16.00
Room: Exhibit A
Session title: Electrophysiology
  Andreas Warnke, Germany Chair
     
  Guided Poster Tour
Time: 14.30-16.00
Room: Exhibit A
Session title: Pathophysiology adult
  Andreas Fallgatter, Germany Chair
     
  Guided Poster Tour
Time: 14.30-16.00
Room: Exhibit A
Session title: Pathophysiology children and adolescents
  Tobias Banaschewski, Germany Chair
     
  Guided Poster Tour
Time: 14.30-16.00
Room: Exhibit A
Session title: Neuroimaging
  Katya Rubia, United Kingdom Chair
     
  Guided Poster Tour
Time: 14.30-16.00
Room: Exhibit A
Session title: Experimental models
  Peter Riederer, Germany Chair
     
  Guided Poster Tour
Time: 14.30-16.00
Room: Exhibit A
Session title: Non pharmacological treatment - Childhood/Adolescence I
  Daniel Brandeis, Switzerland Chair
     
  Guided Poster Tour
Time: 14.30-16.00
Room: Exhibit A
Session title: Non pharmacological treatment - Childhood/Adolescence II
  Lily Hechtman, Canada Chair
     
001 Efficacy of computer-based cognitive training for children and adolescents with ADHD  
  Kritika Mehta, India Presenter
002 Determining the effectiveness of emotion-focused therapy (EFT) on reduction of anxiety and stress among boys contracted Attention-Deficit/Hyperactivity Disorder  
  Mehrnoush Darini, Iran Presenter
003 Determining the effectiveness of group play therapy on the reduction of morbid symptoms among students contracted Attention-Deficit/Hyperactivity Disorder  
  Mehrnoush Darini, Iran Presenter
004 The study of schema therapy on the reduction of depression of mothers with ADHD children  
  Mehrnoush Darini, Iran Presenter
005 Efficacy of a device that combines neurofeedback, motion biofeedback and cognitive attention training for ADHD in children: a randomised single-blind, controlled interventional study  
  Sandeep Vaishnavi, USA Presenter
006 Early identification of and facilitation for children with symptoms of ADHD in preschool  
  Kenneth Larsen, Norway Presenter
007 The effect of cognitive computer training on cognition and symptoms in children with Attention-Deficit/Hyperactivity Disorder (ADHD): Results from a randomized, controlled trial.  
  Aida Bikic, Denmark Presenter
008 Treating ADHD with white noise: Is the Smartnoise application a possible non-pharmacological alternative treatment of inattention in school?  
  Göran Söderlund, Norway Presenter
009 Mental health integration in primary care: Preliminary results from an ADHD program in a family health team  
  Walaa Gomaa, Canada Presenter
010 Effects of neurofeedback training on reducing emotional and behaviour problems in children with ADHD: A pilot study in Taiwan  
  Li Yu Shyu, Taiwan Presenter
     
  Guided Poster Tour
Time: 14.30-16.00
Room: Exhibit A
Session title: Pharmacological treatment children and adolescents I
  Alessandro Zuddas, Italy Chair
     
001 Effect of methylphenidate on attentional fluctuations and slowness in ADHD children with and without epilepsy  
  Patrick Berquin, France Presenter
002 A posteriori individualisation of methylphenidate regimens in ADHD treatment  
  Philippe Robaey, Canada Presenter
003 Selecting the best option among comparable methylphenidate regimens using a performance-based algorithm  
  Philippe Robaey, Canada Presenter
004 Herb-drug interactions in paediatric Attention-Deficit/Hyperactivity Disorder: Examining the safety of herbal medicines  
  Hajra Mazhar, Canada Presenter
005 A personalized medicine approach to ADHD: Patient factors in selecting ADHD pharmacological agents  
  Noel Amaladoss, Canada Presenter
006 Factors related to dropout from methylphenidate of adolescents with ADHD  
  Diana Guizar-Sánchez, Mexico Presenter
008 ADHD and comorbidities in the Indian region - how essential is pharmcotherapy?  
  Aravind Vaithiyam, India Presenter
009 Is video-assisted methylphenidate dose finding for children with ADHD a suitable procedure for medical practitioners? Results after 4-year follow-up  
  Hans-Juergen Kuehle, Germany Presenter
010 Efficacy and safety of HLD200, a novel delayed-release and extended-release methylphenidate formulation, in children with Attention-Deficit/Hyperactivity Disorder: Results from a pivotal phase 3 trial  
  Steven Pliszka, USA Presenter
011 Dose proportionality and effect of food on the pharmacokinetics of HLD200, a novel delayed-release and extended-release methylphenidate formulation in healthy adults  
  Floyd Sallee Presenter
012 Dasotraline efficacy throughout the day in children with attention deficit hyperactivity disorder: Results of a phase 3, randomized, double-blind, placebo-controlled study in a laboratory classroom setting  
  Sharon Wigal, USA Presenter
     
  Guided Poster Tour
Time: 14.30-16.00
Room: Exhibit A
Session title: Pharmacological treatment children and adolescents II
  David Coghill, Australia Chair
     
001 Double-blind, placebo-controlled study of the novel therapeutic AEVI-001 in adolescents with ADHD and glutamatergic network gene mutations  
  Liza Squires, USA Presenter
003 The comparison of methylphenidate and atomoxetine on cognitive functions in children and adolescents with ADHD: A meta-analysis  
  Jiaojiao Ren, China, People's Republic of Presenter
004 Cognitive function in children and adolescents with ADHD receiving lisdexamfetamine dimesylate in a 2-year safety study  
  David Coghill, Australia Presenter
005 Growth and sexual maturation in a two-year, open-label clinical study of lisdexamfetamine dimesylate in children and adolescents with ADHD  
  David Coghill, Australia Presenter
006 Weight and height in children and adolescents with Attention-Deficit/Hyperactivity Disorder: A longitudinal database study assessing the impact of guanfacine, stimulants or no pharmacotherapy  
  William Spalding, USA Presenter
007 Treatment patterns, resource utilisation, and healthcare costs associated with the use of atypical antipsychotics or guanfacine extended release in stimulant-treated children and adolescents with ADHD in Quebec  
  Judy van Stralen, Canada Presenter
008 Long-term safety and efficacy of guanfacine extended release in children and adolescents with ADHD  
  Jeffrey Newcorn, USA Presenter
009 Clinical investigation of children with ADHD treated with atomoxetine oral solution  
  Takashi Ichiyama, Japan Presenter
010 Increase in prescription rates of ADHD medication from pharmacy data within an urban child and adolescent specialist clinic in London. There was a decline in the use of newer preparations  
  Omer Moghraby, United Kingdom Presenter
     
  Guided Poster Tour
Time: 14.30-16.00
Room: Exhibit A
Session title: Treatment adults
  Wolfgang Retz, Germany Chair
     
  Guided Poster Tour
Time: 14.30-16.00
Room: Exhibit A
Session title: Quality of life / Caregiver burden II
  Iris Manor, Israel Chair
     
  Guided Poster Tour
Time: 14.30-16.00
Room: Exhibit A
Session title: Miscellaneous
  Klaus W. Lange, Germany Chair
     
001 Using Xiang thinking to explore the role of "wind" in ADHD  
  Wang Sumei, China, People's Republic of Presenter
003 Screening tool for the detection of specific learning disorders  
  Jesús Luna, Mexico Presenter
004 Influence of parental depression and suicidal ideation on adolescents' suicidal ideation: The 2008-2013 Korean national health and nutrition examination survey (KNHNE)  
  Yeon Jung Lee, Korea, Republic of Presenter
006 A survey of adolescents to assess their knowledge of Attention-Deficit/Hyperactivity Disorder, how different medications work and enhance their understanding through an illustrated leaflet using the analogy of postmen  
  Chinnaiah Yemula, United Kingdom Presenter
007 A survey of parents of teenagers with ADHD to assess their baseline knowledge, how different ADHD medications work and to enhance their understanding through an illustrated leaflet using the analogy of postmen  
  Chinnaiah Yemula, United Kingdom Presenter
009 Comparison attribution style in children with ADHD, depression and normally developing children  
  Haeideh Saberi, Iran Presenter
010 Embelin-loaded nanolipid carriers ameliorate ethanol-induced experimental Attention-Deficit/Hyperactivity Disorder in rats: Possible role of dopamine  
  Raj Kumar Narang, India Presenter
013 The purple hex: Psychosis associated with abuse of propylhexedrine nasal inhalers by a young adult with history of ADHD seeking replacement for stimulant medication - with literature review and historical context  
  Abigail Cohen, USA Presenter
014 The approach of the publications from Brazilian psychologists on ADHD, a categorization research  
  Naiara Perin Darim, Brazil Presenter
     
  Guided Poster Tour
Time: 15.00-16.00
Room: Exhibit A
Session title: Quality of life / Caregiver burden I
  Desiree Silva, Australia Chair
     
  Hot Topic Symposium
Time: 16.00-17.30
Room: Ballroom BC
Session title: Diagnosis and treatment of early morning impairments in ADHD
  Stephen Faraone, USA Chair
  Russel Schachar, Canada Co-Chair
     
  Hot Topic Symposium
Time: 16.00-17.30
Room: Ballroom A
Session title: Frontiers and commonalities between ADHD and other disorders
  Katya Rubia, United Kingdom Chair
  Rosemary Tannock, Canada Co-Chair
     
  Hot Topic Symposium
Time: 16.00-17.30
Room: East Meetingroom 11/12
Session title: ADHD and health risk behaviours
  Sandra Kooij, Netherlands Chair
  James Swanson, USA Co-Chair
     
  Hot Topic Symposium
Time: 16.00-17.30
Room: East Meetingroom 8/15
Session title: Anxiety disorders and adult ADHD across the life cycle
  Frederick Reimherr, USA Chair
  Cesar Soutullo, Spain Co-Chair
     
  Hot Topic Symposium
Time: 16.00-17.30
Room: East Meetingroom 9
Session title: Comorbidity of adult ADHD with mood disorders ? Mechanisms and genetics
  Barbara Franke, Netherlands Chair
  Andreas Reif, Germany Co-Chair
     
  Free communication
Time: 16.00-17.30
Room: East Meetingroom 13
Session title: Free Communication Session
  Luis Augusto Rohde, Brazil Chair
  Joseph A. Sergeant, Netherlands Co-Chair
     
  Meet the Experts
Time: 17.45-18.45
Room: Ballroom A
Session title: Guidelines for assessing adverse events associated to ADHD medication
     
  Meet the Experts
Time: 17.45-18.45
Room: Ballroom BC
Session title: New advances on ADHD genetics and how they might inform clinical practice
     
  Educational Seminar
Time: 17.45-18.45
Room: East Meetingroom 11/12
Session title: Organisation and carrying out of parent training in ADHD
     
  Educational Seminar
Time: 17.45-18.45
Room: East Meetingroom 8/15
Session title: CADDRA: From guidelines to advocacy
     
  CADDRA: From Guidelines to Advocacy  
  Doron Almagor, Canada Speaker
  Don Duncan, Canada Speaker
     
  Educational Seminar
Time: 17.45-18.45
Room: East Meetingroom 9
Session title: New assessment strategies of ADHD in adults
     
  New assessment strategies of ADHD in adults  
  Alexandra Philipsen, Germany Speaker
  Wolfgang Retz, Germany Speaker
     
  Educational Seminar
Time: 17.45-18.45
Room: East Meetingroom 13
Session title: Treatment of ADHD and substance abuse